The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Cardinal Health Inc

NYSE: CAH
Last

(U.S.) $83.34

Today's change0.00 0.00%
Updated July 30 4:00 PM EDT. Delayed by at least 15 minutes.
 

Cardinal Health Inc

NYSE: CAH
Last

(U.S.) $83.34

Today's change0.00 0.00%
Updated July 30 4:00 PM EDT. Delayed by at least 15 minutes.

Cardinal Health Inc closed at (U.S.)$83.34.

Shares have lost 1.10% over the last five days, but have gained 3.23% over the last year to date. This security has outperformed the S&P 500 by 7.52% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $83.34
  • High--
  • Low--
  • Bid / Ask(U.S.) $0.00 / (U.S.) $92.38
  • YTD % change+3.23%
  • Volume0
  • Average volume (10-day)2,734,918
  • Average volume (1-month)2,546,559
  • Average volume (3-month)2,430,894
  • 52-week range(U.S.) $68.54 to (U.S.) $91.91
  • Beta0.65
  • Trailing P/E24.34×
  • P/E 1 year forward16.85×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.55
  • Dividend yield1.86%
  • Trailing EPS(U.S.) $3.42
Updated July 30 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue25,37525,53724,07022,894
Total other revenue--------
Total revenue25,37525,53724,07022,894
Gross profit1,4591,4541,3411,256
Total cost of revenue23,91624,08322,72921,638
Total operating expense24,78425,05123,60422,507
Selling / general / administrative780815775779
Research & development--------
Depreciation / amortization77605363
Interest expense (income), net operating--------
Unusual expense (income)11934727
Other operating expenses, total--------
Operating income591486466387
Interest income (expense), net non-operating-35-36-34-33
Gain (loss) on sale of assets--------
Other--------
Income before tax558451435357
Income after tax365289266234
Income tax, total193162169123
Net income365289266234
Total adjustments to net income--------
Net income before extra. items365289266234
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items365289266234
Inc. avail. to common incl. extra. items365289266234
Diluted net income365289266234
Dilution adjustment--------
Diluted weighted average shares334334340342
Diluted EPS excluding extraordinary itemsvalue per share1.090.870.780.68
Dividends per sharevalue per share0.340.340.340.35
Diluted normalized EPSvalue per share1.111.040.870.74